Axogen, Inc. Amortization of Debt Discount (Premium)
Axogen, Inc. (AXGN) reported Amortization of Debt Discount (Premium) of $161.53 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2014-03-06
- Axogen, Inc. amortization of debt discount (premium) for the quarter ending 2012-12-31 was $124.72K, a 921.73% increase year-over-year.
- Axogen, Inc. amortization of debt discount (premium) for the quarter ending 2012-09-30 was $12.30K, a 1229900.00% increase year-over-year.
- Axogen, Inc. amortization of debt discount (premium) for the quarter ending 2012-06-30 was $12.27K, a 329.40% increase year-over-year.
- Axogen, Inc. amortization of debt discount (premium) for the quarter ending 2012-03-31 was $12.24K, a 42.67% increase year-over-year.
- Axogen, Inc. amortization of debt discount (premium) for fiscal 2012 was $161.53K, a 583.20% increase from fiscal 2011.
- Axogen, Inc. amortization of debt discount (premium) for fiscal 2011 was $23.64K, a 78.23% decline from fiscal 2010.
- Axogen, Inc. amortization of debt discount (premium) for fiscal 2010 was $108.58K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2012-12-31 | $124.72K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | $137.02K derived: sum of 2 quarters · filed 2014-03-06 | $149.29K derived: sum of 3 quarters · filed 2014-03-06 | $161.53K 10-K · filed 2014-03-06 |
| 2012-09-30 | $12.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $24.57K derived: sum of 2 quarters · filed 2013-10-30 | $36.81K 10-Q · filed 2013-10-30 | $49.01K derived: sum of 4 quarters · filed 2013-10-30 |
| 2012-06-30 | $12.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $24.51K 10-Q · filed 2013-08-14 | $36.71K derived: sum of 3 quarters · filed 2013-08-14 | $36.71K derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $12.24K 10-Q · filed 2013-04-30 | $24.45K derived: sum of 2 quarters · filed 2013-08-07 | $24.45K derived: sum of 3 quarters · filed 2013-08-07 | $27.30K derived: sum of 4 quarters · filed 2013-08-07 |
| 2011-12-31 | $12.21K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07 | $12.21K derived: sum of 2 quarters · filed 2013-08-07 | $15.06K derived: sum of 3 quarters · filed 2013-08-07 | $23.64K 10-K/A · filed 2013-08-07 |
| 2011-09-30 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $2.86K derived: sum of 2 quarters · filed 2012-11-06 | $11.44K 10-Q · filed 2012-11-06 | $94.28K derived: sum of 4 quarters · filed 2012-11-06 |
| 2011-06-30 | $2.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $11.44K 10-Q · filed 2012-08-14 | $94.28K derived: sum of 3 quarters · filed 2012-08-14 | |
| 2011-03-31 | $8.58K 10-Q · filed 2012-05-15 | $91.43K derived: sum of 2 quarters · filed 2012-05-15 | ||
| 2010-12-31 | $82.85K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $108.58K 10-K · filed 2012-03-15 | ||
| 2010-09-30 | $25.73K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |